FamiCordTx
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms (NCT06593145) | FamiCordTx | 2023-05-24 |
Track FamiCordTx automatically
Every clearance here is in the API, with alerts when new ones post.